An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells

Melanoma persister cells are tolerant to anti-BRAF and anti-MEK inhibition and can trigger cancer relapse. Here the authors show that a subset of N6-methyladenosine modified mRNAs is translationally activated in persister cells. This preferential translation can be abrogated via eIF4A inhibition.

Bibliografiske detaljer

Principais autores:	Shensi Shen, Sara Faouzi, Amandine Bastide, Sylvain Martineau, Hélène Malka-Mahieu, Yu Fu, Xiaoxiao Sun, Christine Mateus, Emilie Routier, Severine Roy, Laurent Desaubry, Fabrice André, Alexander Eggermont, Alexandre David, Jean-Yves Scoazec, Stéphan Vagner, Caroline Robert
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Portfolio 2019-12-01
Serier:	Nature Communications
Online adgang:	https://doi.org/10.1038/s41467-019-13360-6
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!